Literature DB >> 5423901

IgM turnover in Crohn's disease.

K B Jensen, N Goltermann, S Jarnum, B Weeke, H Westergaard.   

Abstract

Simultaneous turnover studies with radioiodine-labelled IgM and IgG were made in 12 patients with Crohn's disease. Intestinal protein loss was estimated by means of (59)Fe-labelled iron dextran. The serum levels of IgM, IgG, and IgA were normal in most cases. The catabolic rate of IgM was increased in all but one case. A positive correlation was present between the catabolic rate and serum concentration of IgM, an observation which, so far, has been made only in Crohn's disease. The synthetic rate of IgM was raised or high normal in four cases with an intraabdominal abscess. It was normal in the remaining cases. A strong positive correlation was found between the synthetic rates of IgM and IgG. The size of the protein loss was unrelated to the raised catabolic rates of IgM and IgG.Faecal radioiodine excretion from labelled IgM and IgG bore no relation to faecal (59)Fe excretion, nor did it indicate the site of the intestinal lesion. However, a close correlation was observed between faecal excretion of the labels from IgM and IgG.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5423901      PMCID: PMC1411424          DOI: 10.1136/gut.11.3.223

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  METABOLISM OF HUMAN GAMMA MACROGLOBULINS.

Authors:  W F BARTH; R D WOCHNER; T A WALDMANN; J L FAHEY
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Labelling of plasma proteins with radioactive iodine.

Authors:  A S MCFARLANE
Journal:  Biochem J       Date:  1956-01       Impact factor: 3.857

3.  Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies.

Authors:  S A BERSON; R S YALOW; S S SCHREIBER; J POST
Journal:  J Clin Invest       Date:  1953-08       Impact factor: 14.808

4.  IgG and albumin turnover in Crohn's disease.

Authors:  G Bendixen; S Jarnum; J Soltoft; H Westergaard; B Weeke; M Yssing
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

5.  Quantitative estimation of human immunoglobulins following carbamylation by electrophoresis in antibody-containing agarose.

Authors:  B Weeke
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

6.  Serum immunoglobulins and organ-specific, cellular hypersensitivity in ulcerative colitis and Crohn's disease.

Authors:  B Weeke; G Bendixen
Journal:  Acta Med Scand       Date:  1969 Jul-Aug

7.  Quantitation of gastrointestinal protein loss by means of FE59-labeled iron dextran.

Authors:  S Jarnum; H Westergaard; M Yssing; H Jensen
Journal:  Gastroenterology       Date:  1968-08       Impact factor: 22.682

8.  Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease.

Authors:  J V Jones; J Housley; P M Ashurst; C F Hawkins
Journal:  Gut       Date:  1969-01       Impact factor: 23.059

9.  Metabolism of human gamma-macroglobulin (IgM) in normal man.

Authors:  K B Jensen
Journal:  Scand J Clin Lab Invest       Date:  1969-10       Impact factor: 1.713

  9 in total
  8 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

3.  The immune response to phi chi 174 in man. II. Primary and secondary antibody production in patients with Crohn's disease.

Authors:  R C Bucknall; J V Jones; D B Peacock
Journal:  Am J Dig Dis       Date:  1975-05

4.  Alterations in serum immunoglobulins after resection for ulcerative and granulomatous disease of the intestine.

Authors:  I M Gelernt; D H Present; H D Janowitz
Journal:  Gut       Date:  1972-01       Impact factor: 23.059

5.  Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.

Authors:  I O Auer; S Götz; E Ziemer; H Malchow; H Ehms
Journal:  Gut       Date:  1979-04       Impact factor: 23.059

6.  Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis.

Authors:  B Weeke; S Jarnum
Journal:  Gut       Date:  1971-04       Impact factor: 23.059

7.  Plasma protein turnover (albumin, transferrin, IgG, IgM) in Ménétrier's disease (giant hypertrophic gastritis): evidence of non-selective protein loss.

Authors:  S Jarnum; K B Jensen
Journal:  Gut       Date:  1972-02       Impact factor: 23.059

8.  [The immune competence of patients with Crohn's disease (author's transl)].

Authors:  E Tönnesmann; P A Bürkle; B Schäfer; K Federlin
Journal:  Klin Wochenschr       Date:  1979-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.